Jan Oldenburg

Image of Jan Oldenburg
Norwegian version of this page
Username
Visiting address Sykehusveien 25 1474 Nordbyhagen
Postal address Akershus universitetssykehus 1478 Lørenskog

Publications

  • Aeppli, Stefanie; Schmaus, Martina C.; Eisen, Timothy; Escudier, Bernard; Grünwald, Viktor & Larkin, James [Show all 14 contributors for this article] (2021). First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among experts. ESMO Open. ISSN 2059-7029. 6(1). doi: 10.1016/j.esmoop.2020.100030.
  • Crippa, Alessio; De Laere, Bram; Discacciati, Andrea; Larsson, Berit; Connor, Jason T. & Gabriel, Erin E. [Show all 16 contributors for this article] (2020). The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer. Trials. ISSN 1745-6215. 21(1). doi: 10.1186/s13063-020-04515-8. Full text in Research Archive
  • Aeppli, Stefanie; Eboulet, Eric Innocents; Eisen, Timothy; Escudier, Bernard; Fischer, Stefanie & Larkin, James [Show all 15 contributors for this article] (2020). Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma. ESMO Open. ISSN 2059-7029. 5(3). doi: 10.1136/esmoopen-2020-000852.
  • Skalleberg, Jakob Rasmussen; Småstuen, Milada Cvancarova; Oldenburg, Jan; Osnes, Terje; Fosså, Sophie Dorothea & Bunne, Bodil Iris Marie (2020). The relationship between cisplatin-related and age-related hearing loss during an extended follow-up. The Laryngoscope. ISSN 0023-852X. 130(9), p. E515–E521. doi: 10.1002/lary.28543.
  • Normann, Marius; Turzer, Martin; Diep, Lien My; Oldenburg, Jan; Gajdzik, Beata & Popova, Olesya [Show all 7 contributors for this article] (2019). Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancer. Journal of Gynecologic Oncology (JGO). ISSN 2005-0380. 30(4), p. 1–10. doi: 10.3802/jgo.2019.30.e56.
  • Williams, Stephen B.; Ray-Zack, Mohamed D.; Hudgins, Hogan K.; Oldenburg, Jan; Trinh, Quoc-Dien & Nguyen, Paul L. [Show all 10 contributors for this article] (2019). Impact of centralizing care for genitourinary malignancies to high-volume providers: A systematic review. European Urology Oncology (EUO). ISSN 2588-9311. 2(3), p. 265–273. doi: 10.1016/j.euo.2018.10.006.
  • Horwich, Alan; Babjuk, M; Bellmunt, J; Bruins, HM; Reijke, T M De & Santis, M De [Show all 121 contributors for this article] (2019). EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. Annals of Oncology. ISSN 0923-7534. 30(11), p. 1697–1727. doi: 10.1093/annonc/mdz296.
  • Hjelle, Line Veronika; Gundersen, Per Ole Mobråten; Hellesnes, Ragnhild; Sprauten, Mette; Brydøy, Marianne & Tanstad, Torgrim [Show all 11 contributors for this article] (2018). Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors. Acta Oncologica. ISSN 0284-186X. 57(10), p. 1392–1400. doi: 10.1080/0284186X.2018.1473641.
  • Honecker, F; Aparicio, J; Berney, D; Beyer, J; Bokemeyer, C & Cathomas, R [Show all 36 contributors for this article] (2018). ESMO consensus conference on testicular germ cell cancer: Diagnosis, treatment and follow-up. Annals of Oncology. ISSN 0923-7534. 29(8), p. 1658–1686. doi: 10.1093/annonc/mdy217.
  • Boormans, Joost L.; Mayor de Castro, Javier; Marconi, Lorenzo; Yuan, Yuhong; Laguna Pes, M. Pilar & Bokemeyer, Carsten [Show all 10 contributors for this article] (2018). Testicular tumour size and rete testis invasion as prognostic factors for the risk of relapse of clinical stage I seminoma testis patients under surveillance: a systematic review by the Testicular Cancer Guidelines panel. European Urology. ISSN 0302-2838. 73(3), p. 394–405. doi: 10.1016/j.eururo.2017.09.025.
  • Beisland, Christian; Johannessen, Tom Børge; Klepp, Olbjørn; Axcrona, Ulrika; Torgersen, Knut Martin & Kowalski, Jan [Show all 9 contributors for this article] (2017). Overall Survival in Renal Cell Carcinoma after Introduction of Targeted Therapies: A Norwegian Population-Based Study. OncoTargets and Therapy. ISSN 1178-6930. 10, p. 371–385. doi: 10.2147/OTT.S123061.
  • Hjelle, Line Veronika; Bremnes, Roy M.; Gundersen, Per Ole Mobråten; Sprauten, Mette; Brydøy, Marianne & Tandstad, Torgrim [Show all 10 contributors for this article] (2016). Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors. Urologic Oncology. ISSN 1078-1439. 34(487), p. e13–e20. doi: 10.1016/j.urolonc.2016.06.012.
  • Gerwing, Mirjam; Jacobsen, Christine; Dyshlovoy, Sergey; Hauschild, Jessica; Rohlfing, Tina & Oing, Christoph [Show all 12 contributors for this article] (2016). Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells. Journal of Cancer Research and Clinical Oncology. ISSN 0171-5216. 142(9), p. 1979–1994. doi: 10.1007/s00432-016-2204-6.
  • Oldenburg, Jan & Dieckmann, Klaus-Peter (2016). Contralateral biopsies in patients with testicular germ cell tumours: What is the rationale? World Journal of Urology. ISSN 0724-4983. p. 1–6. doi: 10.1007/s00345-016-1945-9.
  • Rothermundt, C.; von Rappard, J.; Eisen, T.; Escudier, B.; Grunwald, V. & Larkin, J. [Show all 13 contributors for this article] (2016). Second-line treatment for metastatic clear cell renal cell cancer: experts’ consensus algorithms. World Journal of Urology. ISSN 0724-4983. p. 1–8. doi: 10.1007/s00345-016-1903-6.
  • Dahl, Alv A; Østby-Deglum, Marie; Oldenburg, Jan; Bremnes, Roy M.; Dahl, Olav & Klepp, Olbjørn [Show all 8 contributors for this article] (2016). Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findings. Journal of cancer survivorship. ISSN 1932-2259. 10(5), p. 842–849. doi: 10.1007/s11764-016-0529-4.
  • Tandstad, Torgrim; Ståhl, Olof; Dahl, Olav; Haugnes, Hege Sagstuen; Håkansson, Ulf & Karlsdottir, Åsa [Show all 17 contributors for this article] (2016). Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: A report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA). Annals of Oncology. ISSN 0923-7534. 27(7), p. 1299–1304. doi: 10.1093/annonc/mdw164.
  • Sprauten, Mette; Haugnes, Hege Sagstuen; Brydøy, Marianne; Kiserud, Cecilie E.; Tandstad, Torgrim & Bjøro, Trine [Show all 10 contributors for this article] (2015). Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors. Annals of Oncology. ISSN 0923-7534. 26(10), p. 2133–2140. doi: 10.1093/annonc/mdv328.
  • Oldenburg, Jan (2015). Hypogonadism and fertility issues following primary treatment for testicular cancer. Urologic Oncology. ISSN 1078-1439. 33(9), p. 407–412. doi: 10.1016/j.urolonc.2015.01.014.
  • Albers, Peter; Albrecht, Walter; Algaba, Ferran; Bokemeyer, Carsten; Cohn-Cedermark, Gabriella & Fizazi, Karim [Show all 10 contributors for this article] (2015). Guidelines on testicular cancer: 2015 update. European Urology. ISSN 0302-2838. 68(6), p. 1054–1068. doi: 10.1016/j.eururo.2015.07.044.
  • Tandstad, Torgrim; Solberg, Arne; Håkansson, Ulf; Stahl, Olof; Haugnes, Hege Sagstuen & Oldenburg, Jan [Show all 10 contributors for this article] (2015). Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols. Acta Oncologica. ISSN 0284-186X. 54(4), p. 493–499. doi: 10.3109/0284186X.2014.953256.
  • Oldenburg, Jan; Aparicio, J; Beyer, J.; Cohn-Cedermark, G; Cullen, M & Gilligan, T. [Show all 19 contributors for this article] (2015). Personalizing, not patronizing: The case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Annals of Oncology. ISSN 0923-7534. 26(5), p. 833–838. doi: 10.1093/annonc/mdu514.
  • Haugnes, Hege Sagstuen; Oldenburg, Jan & Bremnes, Roy M. (2015). Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors. Urologic Oncology. ISSN 1078-1439. 33(9), p. 399–406. doi: 10.1016/j.urolonc.2014.11.012.
  • Rothermundt, Christian; Bailey, Alexandra; Cerbone, Linda; Eisen, Tim; Escudier, Bernard & Gillessen, Silke [Show all 15 contributors for this article] (2015). Algorithms in the first-line treatment of metastatic clear cell renal cell carcinoma—analysis using diagnostic nodes. The Oncologist. ISSN 1083-7159. 20(9), p. 1028–1035. doi: 10.1634/theoncologist.2015-0145.
  • Hjelle, Line Veronika; Gundersen, Per Ole M.; Oldenburg, Jan; Brydøy, Marianne; Tandstad, Torgrim & Wilsgaard, Tom [Show all 9 contributors for this article] (2015). Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: A 20-year follow-up study. Anticancer Research. ISSN 0250-7005. 35(3), p. 1619–1625.
  • Aschim, Elin Leirvoll; Oldenburg, Jan; Kristiansen, Wenche; Giwercman, Aleksander; Witczak, Oliwia & Fosså, Sophie Dorothea [Show all 7 contributors for this article] (2014). Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones. Human Reproduction. ISSN 0268-1161. 29(12), p. 2844–2851. doi: 10.1093/humrep/deu274.
  • Tandstad, Torgrim; Ståhl, Olof; Håkansson, Ulf; Dahl, Olav; Haugnes, Hege Sagstuen & Klepp, Olbjørn [Show all 16 contributors for this article] (2014). One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group. Annals of Oncology. ISSN 0923-7534. 25(11), p. 2167–2172. doi: 10.1093/annonc/mdu375.
  • Sprauten, Mette; Brydøy, Marianne; Haugnes, Hege Sagstuen; Småstuen, Milada Cvancarova; Bjøro, Trine & Berner, Johan [Show all 8 contributors for this article] (2014). Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors. Journal of Clinical Oncology. ISSN 0732-183X. 32(6), p. 571–578. doi: 10.1200/JCO.2013.51.2715.
  • Putora, Paul Martin & Oldenburg, Jan (2013). Swarm-Based Medicine. Journal of Medical Internet Research. ISSN 1438-8871. 15(9), p. 3–6. doi: 10.2196/jmir.2452.
  • Oldenburg, Jan; Fosså, Sophie Dorothea; Nuver, Janine; Heidenreich, Axel; Schmoll, Hans-Joachim & Bokemeyer, Carsten [Show all 9 contributors for this article] (2013). Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. ISSN 0923-7534. 24, p. 125–132. doi: 10.1093/annonc/mdt304.
  • Beyer, Jörg; Albers, P; Altena, R; Aparicio, J; Bokemeyer, C & Busch, J [Show all 59 contributors for this article] (2013). Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Annals of Oncology. ISSN 0923-7534. 24(4), p. 878–888. doi: 10.1093/annonc/mds579.
  • Bachner, Mark; Loriot, Yohann; Gross-Goupil, Marine; Zucali, Paolo Andrea; Horwich, Alan & Germa-Lluch, Josep Ramon [Show all 22 contributors for this article] (2012). 2-(18)fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial. Annals of Oncology. ISSN 0923-7534. 23(1), p. 59–64. doi: 10.1093/annonc/mdr052.
  • Daneshmand, Siamak; Albers, Peter; Fosså, Sophie Dorothea; Heidenreich, Axel; Kollmannsberger, Christian & Krege, Susan [Show all 9 contributors for this article] (2012). Contemporary Management of Postchemotherapy Testis Cancer. European Urology. ISSN 0302-2838. 62(5), p. 867–876. doi: 10.1016/j.eururo.2012.08.014.
  • Sprauten, Mette; Darrah, Thomas H; Peterson, Derick R.; Campbell, M Ellen; Hannigan, Robyn E & Cvancarova, Milada [Show all 11 contributors for this article] (2012). Impact of Long-Term Serum Platinum Concentrations on Neuro- and Ototoxicity in Cisplatin-Treated Survivors of Testicular Cancer. Journal of Clinical Oncology. ISSN 0732-183X. 30(3), p. 300–307. doi: 10.1200/JCO.2011.37.4025.
  • Haugnes, Hege Sagstuen; Bosl, Geroge J; Boer, Hink; Gietema, Jourik A.; Brydøy, Marianne & Oldenburg, Jan [Show all 9 contributors for this article] (2012). Long term and late effects of germ cell testicular cancer treatment and implications for follow-up. Journal of Clinical Oncology. ISSN 0732-183X. 30(30), p. 3752–3763. doi: 10.1200/JCO.2012.43.4431.
  • Oldenburg, Jan; Lorch, Anja & Fosså, Sophie Dorothea (2011). Late Relapse of Germ Cell Tumors. Hematology/Oncology Clinics of North America. ISSN 0889-8588. 25(3), p. 615–+. doi: 10.1016/j.hoc.2011.03.006.
  • Fosså, Sophie Dorothea; Småstuen, Milada C; Chen, Linlin; Allan, Annie L.; Oldenburg, Jan & Peterson, Derick R. [Show all 7 contributors for this article] (2011). Adverse Prognostic Factors for Testicular Cancer-Specific Survival: A Population-Based Study of 27,948 Patients. Journal of Clinical Oncology. ISSN 0732-183X. 29(8), p. 963–970. doi: 10.1200/JCO.2010.32.3204.
  • Stephenson, Andrew J; Aprikan, Armen G; Gilligan, Timothy D; Oldenburg, Jan; Powles, Tom & Toner, Guy C. [Show all 7 contributors for this article] (2011). Management of Low-stage Nonseminomatous Germ Cell Tumors of Testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. Urology. ISSN 0090-4295. 78(4), p. S444–S455. doi: 10.1016/j.urology.2011.02.030.
  • Oldenburg, Jan & Fosså, Sophie D. (2009). Late relapse of nonseminomatous germ cell tumours. BJU International. ISSN 1464-4096. 104(9B), p. 1413–1417.
  • Kraggerud, Sigrid M.; Oldenburg, Jan; Alnæs, Grethe Irene Grenake; Berg, Marianne; Kristensen, Vessela N. & Fosså, Sophie D. [Show all 7 contributors for this article] (2009). Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology. Pharmacogenetics & Genomics. ISSN 1744-6872. 19(10), p. 751–759.
  • Oldenburg, Jan & Fosså, Sophie D. (2009). Exploration of platinum - induced neuropathy should be based on both objective and subjective examinations. Acta Oncologica. ISSN 0284-186X. 48(6), p. 804–806.
  • Oldenburg, Jan; Wahlqvist, Rolf & Fosså, Sophie D. (2009). Late relapse of germ cell tumors. World Journal of Urology. ISSN 0724-4983. 27(4), p. 493–500.
  • Oldenburg, Jan & Fosså, Sophie D. (2009). Long-term toxicity after therapy for testicular cancer with special focus on sexual disorders. Der Urologe. ISSN 0340-2592. 48(4), p. 372–376.
  • Brydøy, Marianne; Oldenburg, Jan; Klepp, Olbjørn; Bremnes, Roy M.; Wist, E. & Wentzel-Larsen, Tore [Show all 9 contributors for this article] (2009). Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors. Journal of the National Cancer Institute. ISSN 0027-8874. 101(24), p. 1682–1695.
  • Oldenburg, Jan; Wahlqvist, Rolf & Fosså, Sophie Dorothea (2009). Late relapse of germ cell tumors. World Journal of Urology. ISSN 0724-4983. 27(4), p. 493–500. doi: 10.1007/s00345-009-0411-3.
  • Brydøy, Marianne; Oldenburg, Jan; Oldenburg, J; Klepp, Olbjørn; Bremnes, Roy M. & Wist, Erik [Show all 11 contributors for this article] (2009). Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors. Journal of the National Cancer Institute. ISSN 0027-8874. 101(24), p. 1682–1695. doi: 10.1093/jnci/djp413.
  • Oldenburg, Jan & Fossa, Sofie D (2009). Late relapse of nonseminomatous germ cell tumours. BJU International. ISSN 1464-4096. 104(9B), p. 1413–1417. doi: 10.1111/j.1464-410X.2009.08868.x.
  • Skaali, Tone; Skaali, T; Fossa, SD; Fosså, Sophie D; Bremnes, Roy M. & Dahl, Olav [Show all 13 contributors for this article] (2009). Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology. ISSN 1057-9249. 18(6), p. 580–588. doi: 10.1002/pon.1437.
  • Kraggerud, Sigrid M.; Oldenburg, Jan; Alnaes, GI; Berg, M; Kristensen, Vessela N. & Fosså, Sophie Dorothea [Show all 7 contributors for this article] (2009). Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology. Pharmacogenetics & Genomics. ISSN 1744-6872. 19(10), p. 751–759. doi: 10.1097/FPC.0b013e3283304253.
  • Oldenburg, Jan & Fosså, Sophie Dorothea (2009). Long-term toxicity after therapy for testicular cancer with special focus on sexual disorders. Der Urologe. ISSN 0340-2592. 48(4), p. 372–376. doi: 10.1007/s00120-009-1945-0.
  • Fosså, Sophie Dorothea; Oldenburg, Jan & Dahl, Alv A (2009). Short-and long-term morbidity after treatment for testicular cancer. BJU International. ISSN 1464-4096. 104(9B), p. 1418–1422. doi: 10.1111/j.1464-410X.2009.08869.x.
  • Oldenburg, Jan; Lehne, Gustav & Fosså, Sophie Dorothea (2008). Testikkelkreft. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 128(4), p. 457–460.
  • Skaali, T; Fosså, Sophie Dorothea; Bremnes, R; Dahl, Olav; Haaland, Carl Fredrik & Hauge, Erik R [Show all 10 contributors for this article] (2008). Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology. ISSN 1057-9249. doi: 10.1002/pon.1437.
  • Oldenburg, Jan; Fosså, Sophie Dorothea & Ikdahl, Tone (2008). Genetic variants associated with cisplatin-induced ototoxicity. Pharmacogenomics (London). ISSN 1462-2416. 9(10), p. 1521–1530. doi: 10.2217/14622416.9.10.1521.
  • Oldenburg, Jan; Kraggerud, Sigrid M.; Cvancarova, Milada; Lothe, Ragnhild A & Fosså, Sophie Dorothea (2007). Cisplatin-induced long-term hearing impairment is associated with specific glutathione S-transferase genotypes in testicular cancer survivors. Journal of Clinical Oncology. ISSN 0732-183X. 25, p. 708–714. doi: 10.1200/JCO.2006.08.9599.
  • Oldenburg, Jan; Kraggerud, Sigrid M.; Brydøy, Marianne; Lothe, Ragnhild A.; Fossa, Sophie D. & Fossa, SD (2007). Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study. Journal of Translational Medicine. ISSN 1479-5876. 5. doi: 10.1186/1479-5876-5-70.
  • Oldenburg, Jan; Kraggerud, Sigrid M.; Brydøy, Marianne; Cvancarova, Milada; Lothe, Ragnhild A & Fosså, Sophie Dorothea (2007). Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in lutathione-s-transferase-P1 and -M1, a retrospective cross sectional study. Journal of Translational Medicine. ISSN 1479-5876. 5(1). doi: 10.1186/1479-5876-5-70.
  • Oldenburg, Jan; Fosså, Sophie Dorothea & Dahl, Alv A (2006). Scale for chemotherapy-induced long-term neurotoxicity (SCIN): Psychometrics, validation, and findings in a large sample of testicular cancer survivors. Quality of Life Research. ISSN 0962-9343. 15, p. 791–800.
  • Oldenburg, Jan; Alfsen, GC; Waehre, H & Fosså, Sophie Dorothea (2006). Late recurrences of germ cell malignancies: a population-based experience over three decades. British Journal of Cancer. ISSN 0007-0920. 94, p. 820–827.
  • Oldenburg, Jan; Martin, Jarad M & Fosså, Sophie Dorothea (2006). Late relapses of germ cell malignancies: Incidence, management, and prognosis. Journal of Clinical Oncology. ISSN 0732-183X. 24(35), p. 5503–5511. doi: 10.1200/JCO.2006.08.1836.
  • Oldenburg, Jan; Alfsen, GC; Lien, Hans Henrik; Waehre, Haakon & Fosså, Sophie Dorothea (2005). Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. Journal of Clinical Oncology. ISSN 0732-183X. 23(16).
  • Oldenburg, Jan; Alfsen, G. Cecilie; Lien, Hans Henrik; Aas, Nina; Wæhre, Haakon & Fosså, Sophie Dorothea (2003). Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumour masses. Journal of Clinical Oncology. ISSN 0732-183X. 21, p. 3310–3317.

View all works in Cristin

  • Heinrich, Daniel; Russnes, Kjell Magne & Oldenburg, Jan (2018). Re: Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer. European Urology. ISSN 0302-2838. doi: 10.1016/j.eururo.2018.04.010.
  • Oldenburg, Jan & Gietema, Jourik A. (2016). The sound of silence: A proxy for platinum toxicity. Journal of Clinical Oncology. ISSN 0732-183X. 34(23), p. 2687–2689. doi: 10.1200/JCO.2016.68.2476.
  • Oldenburg, Jan; Haugnes, Hege Sagstuen; Dahl, Olav; Karlsdottir, Åsa; Langberg, Carl W. & Klepp, Olbjørn [Show all 8 contributors for this article] (2015). Behandling ved stadium I-testikkelkreft bør vurderes individuelt. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 135(15), p. 1340–1341. doi: 10.4045/tidsskr.15.0544.
  • Oldenburg, Jan & de Wit, Ronald (2015). Primum non nocere: Of course! But how? Journal of Clinical Oncology. ISSN 0732-183X. 33(20), p. 2320–2320. doi: 10.1200/JCO.2015.61.2291.
  • Oldenburg, Jan; Cullen, M & Tandstad, Torgrim (2014). Primum non nocere: do we harm stage I testicular cancer patients less by applying adjuvant chemotherapy than by failing to present this option? Annals of Oncology. ISSN 0923-7534. 26(2), p. 255–256. doi: 10.1093/annonc/mdu520.
  • Putora, Paul Martin & Oldenburg, Jan (2014). The Kafkaesque process of cancer diagnosis. Journal of Clinical Oncology. ISSN 0732-183X. 32(10), p. 1087–1088. doi: 10.1200/JCO.2013.54.2449.
  • Fung, Chunkit; Fosså, Sophie Dorothea; Oldenburg, Jan; Milano, Michael T. & Travis, Lois B. (2014). Reply to G. Gandaglia et al. Journal of Clinical Oncology. ISSN 0732-183X. 32(11), p. 1167–1169. doi: 10.1200/JCO.2013.54.6168.
  • Tandstad, Torgrim; Stahl, E.; Dahl, Olav; Haugnes, Hege Sagstuen; Langberg, Carl W. & Laurell, Anna [Show all 13 contributors for this article] (2014). Management of clinical stage I seminomatous testicular cancer: A report from SWENOTECA.
  • Sprauten, Mette; Haugnes, Hege Sagstuen; Brydøy, Marianne; Fosså, Sophie Dorothea & Oldenburg, Jan (2013). Impact of testicular scatter radiation (TSR) on testosterone (T) and luteinizing hormone (LH) 11 and 18 years after abdominal radiotherapy for testicular cancer. European Journal of Cancer. ISSN 0959-8049. 49, p. S647–S648.
  • Sprauten, Mette; Cvancarova, Milada; Fosså, Sophie Dorothea; Brydøy, Marianne; Haugnes, Hege Sagstuen & Oldenburg, Jan (2012). Longitudinal serum testosterone levels (T) in long-term testicular cancer survivors (TCSs) in relation to testicular cancer (TC) treatment, aging, and TC diagnosis itself. Journal of Clinical Oncology. ISSN 0732-183X. 30(15).
  • Kersten, Christian; Cameron, Marte G & Oldenburg, Jan (2012). Truth in Hope and Hope in Truth. Journal of Palliative Medicine. ISSN 1096-6218. 15(1), p. 128–129. doi: 10.1089/jpm.2011.0209.
  • Tandstad, Torgrim; Solberg, Arne; Håkansson, Ulf; Angelsen, Anders; Haugnes, Hege Sagstuen & Oldenburg, Jan [Show all 9 contributors for this article] (2012). Bilateral testicular cancer within two prospective, population-based SWENOTECA protocols in clinical stage I nonseminoma. Journal of Clinical Oncology. ISSN 0732-183X. 30(15:4508).
  • Oldenburg, Jan & Fosså, Sophie Dorothea (2011). Cancer Survivorship. European Journal of Cancer. ISSN 0959-8049. 47, p. S36–S36.
  • Oldenburg, Jan & Gietema, Jourik A. (2011). IT'S TIME TO SYSTEMATICALLY INVESTIGATE BIOMARKERS FOR TREATMENT ALLOCATION OF TESTICULAR CANCER PATIENTS. BJU International. ISSN 1464-4096. 107(6), p. 942–943. doi: 10.1111/j.1464-410X.2010.10004.x.
  • Aschim, Elin Leirvoll; Oldenburg, Jan; Kristiansen, Wenche; Fosså, Sophie Dorothea & Haugen, Trine B. (2010). Polymorphisms in CYP genes affect gonadal hormone levels in ≥ 5 years testicular cancer survivors.
  • Aschim, Elin Leirvoll; Oldenburg, Jan; Kristiansen, Wenche; Fosså, Sophie Dorothea & Haugen, Trine B. (2010). Polymorphisms in CYP genes affect gonadal hormone levels in ≥ 5 years testicular cancer survivors.
  • Sprauten, Mette; Darrah, Thomas H.; Hannigan, Robyn E.; Beard, Clair; Haugnes, Hege Sagstuen & Cvancarova, Milada [Show all 10 contributors for this article] (2010). Long-term accumulation of platinum (Pt) and its impact on self-reported neuro-and ototoxicity in cisplatin-treated testicular cancer survivors (TCSs). European Journal of Cancer. ISSN 0959-8049. 8(5), p. 153–154.
  • Travis, LB; Beard, C; Allan, James; Dahl, Alv A; Feldman, D. & Oldenburg, Jan [Show all 22 contributors for this article] (2010). Testicular Cancer Survivorship: Research Strategies and Recommendations. Journal of the National Cancer Institute. ISSN 0027-8874. 102(15), p. 1114–1130. doi: 10.1093/jnci/djq216.
  • Oldenburg, Jan & Fosså, Sophie Dorothea (2009). Exploration of platinum-induced neuropathy should be based on both objective and subjective examinations. Acta Oncologica. ISSN 0284-186X. 48(6), p. 804–806. doi: 10.1080/02841860902984729.
  • Oldenburg, Jan; Kraggerud, Sigrid M.; Grov, Ellen Karine; Dahl, Alv A; Lothe, Ragnhild A & Fosså, Sophie Dorothea (2008). Platinum, polymorphisms, and personality: Impact on long-term neurotoxicity.
  • Oldenburg, Jan & Fosså, Sophie Dorothea (2009). Long-term outcome after treatment for testicular cancer. Unipub forlag. ISSN 978-82-8072-309-3.

View all works in Cristin

Published Nov. 6, 2019 11:15 AM - Last modified Dec. 12, 2019 1:48 PM